Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 15, 2010Boston Scientific to Immediately Resume Distribution of COGNIS® CRT-Ds and TELIGEN® ICDs in the U.S.
Boston Scientific Corporation (NYSE: BSX) today announced that it has received U.S. Food and Drug Administration (FDA) clearance for the two...
-
Apr 15, 2010
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the first quarter ended March 31, 2010...
-
Mar 18, 2010Company's CRT-Ds recommended for asymptomatic and mild heart failure patients
Boston Scientific Corporation (NYSE: BSX) today announced that the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA)...
-
Mar 16, 2010Trials to evaluate small vessel and long lesion versions of platinum chromium PROMUS® Element™ Stent System
Boston Scientific Corporation (NYSE: BSX) today announced the completion of patient enrollment in the Small Vessel and Long Lesion trials of its...
-
Mar 15, 2010Boston Scientific applies to FDA for expanded indications for TAXUS Express and TAXUS® Liberte® Stents in AMI patients
Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of one-year subset data from the HORIZONS AMI trial...
-
Mar 15, 2010
Boston Scientific Corporation (NYSE: BSX) today announced 12-month results from its PERSEUS clinical program that demonstrated...
-
Mar 15, 2010
Boston Scientific Corporation (NYSE: BSX) announced today that it has stopped shipment and is retrieving field inventory of all its implantable...
-
Mar 11, 2010First and only premounted, balloon-expandable stent approved specifically for use in iliac arteries
Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved its Express® LD Iliac...
-
Mar 10, 2010Clinical data presentations to include 12-month results for third-generation TAXUS® Element™ drug-eluting stent
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and news announcements at the 59th Annual...
-
Feb 23, 2010
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the upcoming RBC Capital Markets Health Care Conference in New York City....